iPhone Will Change Health-IT, Says Datamonitor


Loading...

By Neil Versel

March 18, 2008 | Following recent news that drug-reference database vendor Epocrates will be one of the first companies to develop third-party software for the iPhone, a new report suggests the too-cool-for-words Apple product could be the killer app that finally brings physicians into the digital age en masse.

“Apple’s recent announcement that it is allowing third party developers to create applications on the iPhone will have tremendous effects on the health care industry,” says a report from IT market analysis firm Datamonitor (London). “Datamonitor believes that health care technology applications — particularly electronic health records (EHRs) and clinical decision support (CDS) — will be more likely to be adopted by physicians, translating into better health care for patients.”

On Friday, ahead of the Monday release of the report, New York-based Datamonitor analyst Christine Chang put out an independent commentary on the report itself, suggesting that mobile devices could “alleviate” the perceived notion that EHR adoption has been slow in part because computers in the exam room get in the way of the traditional physician-patient relationship.

“The iPhone, however, stands out from the rest of the currently available devices because of its functionality, ease of use and, quite frankly, appearance,” Chang wrote. “The iPhone’s functionality is undisputed — as a phone, camera, media device, and Web browser all in one device — who needs anything else? Health care providers don’t want to carry around a beeper, hospital-issued phone, cell phone, BlackBerry, and tablet PC with them as they run through the corridors of a hospital. They want to carry around one device that can do everything and that’s what the iPhone is.”

Added Chang: “With no little buttons to push, the iPhone’s touch screen brings easy-to-use technology to even the most technophobic provider. Zoom-in capabilities … and the ability to flick through screens are other features that will make it easier, rather than more difficult, for providers to enter in and sort through patient information.”

Chang also noted that the iPhone can connect to the Internet and organizational networks either by Wi-Fi or cellular broadband technology.

She cited the Epocrates decision to produce an iPhone version of its software as an example of how much physician demand there is for clinical applications that work on the Apple device. (See “Epocrates Coming to an iPhone Near You.”)

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

sas_f0910
Rethinking Clinical Trials Data Integration
Sponsored by SAS

There is a gap between the need for data integration and fully integrated systems. To find out why, SAS and Pharmaceutical Executive conducted confidential telephone interviews with senior pharmaceutical executives and CROs. This article discusses recommendations on how to achieve optimal clinical data integration, based on those interviews.



ClearTrial_BriefingOn
eClinical Trial Technologies Revolutionizing Clinical Development Efficiency
Sponsored by ClearTrial
This Bio-IT World BriefingON report, sponsored by ClearTrial, presents a selection of recent stories from Bio•IT World and sister publication, eCliniqua, that illustrate how new technologies and approaches can have a profound impact on the management and execution of clinical trials.


oracle_RDC
Remote Data Capture:Acquisition and Analysis
Sponsored by Oracle

See why Electronic Data Capture (EDC) is gaining traction in the pharmaceutical
clinical trials arena. Today approximately half of all clinical trials are conducted
electronically, and the figure is rapidly rising. Report includes contributions from
Oracle Health Sciences, Pfizer, PPD, and C3i.

 



Life Science Webcasts & Podcasts

Bio-IT World & CHI

Impact of the 1000 Genomes Project on the Next Wave of Pharmacogenomic Discovery
1000genomeInterview with M. Eileen Dolan, Ph.D., Professor, Medicine, University of Chicago and Speaker at Next-Generation Sequencing Data Management, September 27-29, 2010, Providence, RI  

The 1000 Genomes Project aims to provide detailed genetic variation data on >1000 genomes from worldwide populations using the next-generation sequencing technologies. Some of the samples utilized for the 1000 Genomes Project are the International Hap-Map samples that are composed of lymphoblastoid cell lines (LCLs) derived from individuals of different world populations. The detailed map of human genetic variation promised by the 1000 Genomes project will allow a more in-depth analysis of the contribution of genetic variation to drug response. Future studies utilizing this new resource can greatly enhance our understanding of the genetic basis of drug response and other complex traits.


Download Now 



More Podcasts

Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.

Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.